Antiverse logo

Antiverse

Designing functional antibodies for the most challenging targets.

33 employees · est. 2017 · Cardiff, United Kingdom

VS
Tubulis GmbH logo

Tubulis GmbH

Reimagining ADCs.

119 employees · est. 2019 · Germany

Antiverse is the older company (2017 vs 2019); Tubulis GmbH is the larger of the two.

Side-by-Side Comparison

Antiverse Tubulis GmbH
Founded
2017 older 2019
Headquarters
Cardiff, United Kingdom Germany
Employees
33 119 larger
Industry
AI, Biotechnology, Health Care Biotechnology, Health Care, Health and Wellness
Funding Stage
Series A Acquired
Total Funding
$21.82M $3.66B
Funding Rounds
10 11
Services
Antibody design for challenging targets, Pharmaceutical partnerships, In silico drug discovery, Machine learning model development ADC Development, Clinical Research, Biophysical Property Analysis
Target Customers
Pharmaceutical companies, Biotech firms, Healthcare researchers Pharmaceutical Companies, Medical Researchers, Oncologists, Cancer Patients
Taxonomy
Antibody Design, Challenging Drug Targets, GPCR Therapeutics, Ion Channel Therapeutics, TechBio, Cell Line Engineering, De Novo Antibody Therapeutics, Drug Discovery, Structural Biology, Biotechnology Innovation, Therapeutic Antibodies, Accelerated Drug Development, Advanced Therapeutics Antibody Drug Conjugates, Targeted Therapy, Drug Development, Chemotherapy Alternatives, Cancer Treatment, Protein-Drug Conjugates, Disease-Specific Biology, Pharmaceuticals, Chronic Disorder Treatment, Innovative Technology, Oncology
Website
antiverse.io tubulis.com
Antiverse logo

About Antiverse

Antiverse, founded in 2017, is a promising Welsh techbio company that specializes in the design of antibodies targeting difficult drug targets such as GPCRs and ion channels. The company’s mission is encapsulated in its slogan: "Designing functional antibodies for the most challenging targets." Wit...

Tubulis GmbH logo

About Tubulis GmbH

Tubulis GmbH, with its slogan "Reimagining ADCs.", represents a significant stride in the biotechnology space. Founded in 2019, the company quickly positioned itself at the intersection of Biotechnology, Health Care, Health and Wellness, Life Sciences, and Pharmaceutical sectors. Its headquarter is...

We will tell you when either one moves

BounceWatch watches Antiverse and Tubulis GmbH for new funding, fast hiring, new executives and a change of software vendor. When one happens, we email you the same day.

Watch both — free

Funding, hiring, leadership and stack changes at Antiverse and Tubulis GmbH — by email.

Frequently Asked Questions

Antiverse — Designing functional antibodies for the most challenging targets.. Tubulis GmbH — Reimagining ADCs.. Both companies operate in related markets but may differ in funding stage, team size, and product focus.
Antiverse has raised $21.82M while Tubulis GmbH has raised $3.66B.
Antiverse and Tubulis GmbH operate in overlapping markets and are frequently compared. Track both companies on Bounce Watch to monitor their growth signals in real time.

Compare Antiverse with someone else

Start typing a company name or domain.

Compiled from the BounceWatch company index. We last looked at Antiverse on 15 Jun 2026, and Tubulis GmbH on 15 Jun 2026. Where a field is blank here, it means we have not recorded it — not that the answer is zero. How we source and date this.

One analytics cookie (Google Analytics). Cookie Policy